High prevalence of Escherichia coli clinical isolates in India harbouring four amino acid inserts in PBP3 adversely impacting activity of aztreonam/avibactam

J Antimicrob Chemother. 2020 Jun 1;75(6):1650-1651. doi: 10.1093/jac/dkaa021.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amino Acids
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Azabicyclo Compounds
  • Aztreonam* / pharmacology
  • Ceftazidime
  • Drug Combinations
  • Escherichia coli* / genetics
  • India / epidemiology
  • Microbial Sensitivity Tests
  • Prevalence
  • beta-Lactamases / genetics

Substances

  • Amino Acids
  • Anti-Bacterial Agents
  • Azabicyclo Compounds
  • Drug Combinations
  • avibactam
  • Ceftazidime
  • beta-Lactamases
  • Aztreonam